Jyong Biotech Ltd. - Ordinary shares
Jyong Biotech Ltd. - Ordinary shares
Share · KYG831161065 · MENS (XNAS)
Overview
No Price
20.12.2025 00:59
Current Prices from Jyong Biotech Ltd. - Ordinary shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MENS
USD
20.12.2025 00:59
3,25 USD
0,07 USD
+2,31 %
Company Profile for Jyong Biotech Ltd. - Ordinary shares Share
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
AI Analysis of Jyong Biotech Ltd. - Ordinary shares
Click any analysis below to get instant AI insights from finAgent

Company Data

Name Jyong Biotech Ltd. - Ordinary shares
Company Jyong Biotech Ltd. Ordinary Shares
Symbol MENS
Website https://www.jyongbio.com/
Primary Exchange XNAS NASDAQ
ISIN KYG831161065
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Fu-Feng Kuo
Market Capitalization 241 Mio
Country Taiwan
Currency USD
Employees 0,0 T
Address 23F‑3, No. 95, Section 1, Xintai 5th Road, 221 New Taipei City
IPO Date 2025-06-17

Ticker Symbols

Name Symbol
NASDAQ MENS
More Shares
Investors who hold Jyong Biotech Ltd. - Ordinary shares also have the following shares in their portfolio:
MOTABILITY 24/51 MTN
MOTABILITY 24/51 MTN Bond
Zvi Sarfati & Sons Investments & Constructions Ltd.
Zvi Sarfati & Sons Investments & Constructions Ltd. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025